Trial Profile
Evaluation of interventions linked to treatable traits in acute critical illness in adults to enable precision medicine: Data enabled Bayesian adaptive platform randomised clinical trial with embedded biological characterisation (TRAITS Trial)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2023
Price :
$35
*
At a glance
- Drugs Baricitinib (Primary) ; Budesonide (Primary) ; Imatinib (Primary)
- Indications Critical illness; Inflammation; Lymphopenia; Respiratory insufficiency; Shock
- Focus Therapeutic Use
- Acronyms TRAITS
- 08 Nov 2023 Status changed from not yet recruiting to recruiting.
- 08 Nov 2023 Planned initiation date changed from 1 Nov 2023 to 27 Nov 2023.
- 08 Nov 2023 Status changed to not yet recruiting.